Entero Healthcare Solutions' Q2 FY 2026-27 Quarterly Results

Result Summary

• Entero Healthcare Solutions Ltd reported a 7.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 32.7%.
• Its expenses for the quarter were up by 7.3% QoQ and 31.5% YoY.
• The net profit increased 16.7% QoQ and increased 66.0% YoY.
• The earnings per share (EPS) of Entero Healthcare Solutions Ltd stood at 10.45 during Q2 FY 2026-27.

Financial Statments for Q2 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Entero Healthcare Solutions Ltd operates primarily in the healthcare sector, with a focus on providing comprehensive healthcare solutions. The company is known for delivering a range of products and services that cater to various needs within the healthcare industry. As of the latest available data, specific details regarding recent major developments or additional product lines are not readily available. Entero Healthcare Solutions Ltd continues to play a significant role in the industry by leveraging its expertise to address healthcare demands.

Revenue

In Q2FY27, Entero Healthcare Solutions Ltd reported a total income of ₹2091.07 crores, which represents a quarter-over-quarter increase of 7.6% from ₹1943.50 crores in Q1FY27. This also marks a substantial year-over-year growth of 32.7% compared to ₹1575.74 crores in Q2FY26. The consistent increase in total income over these periods reflects a robust upward trend in the company's revenue generation capabilities.

Profitability

The company's Profit Before Tax (PBT) for Q2FY27 stood at ₹78.39 crores, showing a significant increase of 16.8% from the previous quarter's ₹67.12 crores and a remarkable year-over-year growth of 75.7% from ₹44.62 crores in Q2FY26. Profit After Tax (PAT) also exhibited a strong performance, increasing 16.7% QoQ from ₹52.05 crores in Q1FY27 to ₹60.74 crores in Q2FY27, and by 66.0% YoY from ₹36.60 crores in Q2FY26. The tax expense for Q2FY27 was ₹17.64 crores, up 17.1% from Q1FY27 and 120.0% from Q2FY26, indicating a proportional rise with the company's increasing profitability. Earnings per Share (EPS) rose to ₹10.45 from ₹8.76 in Q1FY27, marking a 19.3% QoQ increase, and a 44.1% YoY increase from ₹7.25 in Q2FY26.

Operating Metrics

During Q2FY27, Entero Healthcare Solutions Ltd managed its expenses efficiently, with total expenses amounting to ₹2012.68 crores, reflecting a 7.3% increase from ₹1876.37 crores in Q1FY27 and a 31.5% rise from ₹1531.11 crores in Q2FY26. This controlled increase in expenses, in comparison to the revenue growth, suggests effective operational management. The financial performance, with respect to profitability margins and expenses, indicates a positive trend in operational efficiency over the observed periods.